Melanie Kelly

Melanie Kelly

Company: Tetra Bio-Pharma

Job title: Chief Scientific Officer


Panel Discussion: Effective Preclinical Research and Validating Your Targets 11:30 am

In the context of Medpharm’s current research into degenerative disease, discuss key ideas involved in the phase 1 study design process Consider key target identification principlesRead more

day: Day 2 Track B - Morning

Challenges & Successes in Moving Promising Preclinical Cannabinoid Drug Candidates to the Clinic 1:30 pm

Identify robust pre-clinical drug targets for cannabinoid drug development Evaluate pre- and post-COVID cannabinoid drug development challenges: spotlight on systemic inflammatory disease Examine future development of cannabinoid drug products for expanded disease indicationsRead more

day: Day One Track A - afternoon

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.